Dr. Bray directs the graduate course in Bioterrorism - Related Diseases (MICB-550-01).
-
Edghill-Smith Y, ?Bray M, et al. Modeling a safer smallpox-vaccination regimen for AIDS patients in immunocompromised macaques. J Infect Dis 188:1181-1191.
-
Roy C, Baker R, Washburn K, Bray M. 2003. Aerosolized cidofovir is retained in the respiratory tract and protects mice against intranasal cowpox virus challenge. Antimicrob Agents Chemother 47:2933-2937.
-
Bray M, Mahanty S. 2003. Ebola hemorrhagic fever and septic shock. J Infect Dis 188:1613-1617.
-
Bray M. 2003. 2004. New data in a 200-year investigation. Clin Infect Dis 38:90-1.
-
Bray M. 2004. Pathogenesis of filovirus infection in mice. In: Molecular and Cellular Biology of Marburg and Ebola Viruses, pp 255-278, Horizon Bioscience, Wiltshire, UK.
-
Paragas J, Whitehouse C, Endy T, Bray M. A simple assay for determining antiviral activity against Crimean-Congo hemorrhagic fever virus. Antiviral Res 62:21-5.
-
Bray M, Buller RM. 2004. Looking back at smallpox. Clin Infect Dis 38:882-890.
-
Bray M, Roy CJ. Antiviral prophylaxis of smallpox. J Antimicrob Chemother 54:1-5.
-
Mahanty S, Bray M. Pathogenesis of filoviral hemorrhagic fevers. Lancet Infect Dis 4:487-98.
-
Bray M. Henry Kempe and the birth of VIG. Clin Infect Dis (in press).
-
Bray M. Viral bioterrorism and antiviral countermeasures. In: Antiviral Drug Discovery for Emerging Diseases and Bioterrorism Threats, (Paul Torrence, editor), John Wiley & Sons, Hoboken, NJ (in press).